The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MDS 2021 | Key advances in MDS management
Sandra Kurtin, PhD, ACNP-BC, AOCN, University of Arizona, Tucson, AZ, outlines the key advances in the management of myelodysplastic syndromes (MDS), including the identification of new therapeutic targets, improvements in our understanding of the main drivers of MDS, and enhanced support for patients. This interview took place at the 16th International Congress on Myelodysplastic Syndromes, held virtually in 2021.
